ELAB vs XPON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 16, 2026

ELAB

60.2
AI Score
VS
ELAB Wins

XPON

40.7
AI Score

Investment Advisor Scores

ELAB

60score
Recommendation
BUY

XPON

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ELAB XPON Winner
Revenue 1.99M 3.60M XPON
Net Income -7.91M -3.04M XPON
Gross Margin 31.0% 29.3% ELAB
Net Margin -397.7% -84.6% XPON
ROE -47.3% -63.2% ELAB
ROA -21.6% -49.6% ELAB
Total Assets 36.56M 6.14M ELAB
Cash 18.14M 1.54M ELAB
Current Ratio 1.36 5.55 XPON

Relative Price Performance (Last 90 Days)

ELAB 1M: -16.5% · 3M: -55.8% XPON 1M: +952.0% · 3M: +505.5%

Current Technical Phase

ELAB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -24.3%), weak momentum, RSI 38

RSI (14): 37.8 · Price: $0.91

XPON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (228.4% over 20 days), RSI 70

RSI (14): 70.1 · Price: $3.64

Fundamentals Snapshot

Metric ELAB XPON
Market Cap
Forward P/E 0.0 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth -0.5% -0.3%
Gross Margin -0.6% 0.2%
Operating Margin -4.8% -0.6%
EPS -149.49 -7.50
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ELAB is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.